CClinicalTrials.gg
CompletedNCT07416487Updated Feb 18, 2026

Comparison of Outcome of Foley Catheter Versus Misoprostol for Induction of Labor

An interventional study of Misoprostol and Foley catheter in Labor, sponsored by Muhammad Aamir Latif. Completed at 1 site in Pakistan. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-02-18.

Sponsored by Muhammad Aamir Latif · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Feb 2025, registered Feb 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
76
Allocation
Randomized
Ages
18 Years to 40 Years
Sex
Female
01

Study summary

There are gaps in the local data regarding the comparative effectiveness of Foley catheter versus misoprostol for induction of labor (IOL). Therefore, the current study was planned with the objective of comparing the mean induction-to-delivery interval of Foley catheter versus misoprostol for IOL in singleton term pregnancy.

Read the detailed description

Although systematic reviews and meta-analyses have compared the effectiveness and safety of pharmacologic, nonpharmacologic, mechanical, and combined methods of cervical ripening and labor induction, the optimal method of IOL is still debatable. The findings would be helpful in further assessing the conflicting evidence and furnishing the limited data regarding the use of Foley catheters or misoprostol in patients undergoing IOL from local setups.

02

Conditions studied

  • Labor
03

In context

Lead sponsor

Muhammad Aamir Latif is the lead sponsor of 56 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Pregnant females
  • 18-40 years
  • With a singleton term pregnancy (37-41) weeks
  • Parity \< 4
  • Vertex presentation (on ultrasound scan)
  • Intact membranes (on history and clinical examination)
  • Going through labor induction

Exclusion criteria

Exclusion Criteria:

  • With a previous uterine surgery
  • Non-reassuring cardiotocography (CTG)
  • Oligohydramnios (on ultrasound scan)
  • Intrauterine growth restriction (IUGR) (on ultrasound scan)
  • Abruptio placenta (on ultrasound scan).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
76 participants (actual)

Study arms

  • Experimental
    Misoprostol Group

    Women received intravaginal misoprostol 25 μg 4 hours apart, up to a maximum of four doses.

    Drug: Misoprostol

  • Experimental
    Foley Group

    An intracervical Foley catheter (16 F) was inserted into the patients. The balloon was inflated with 30 mL of sterile normal saline solution and was kept in place until it expelled spontaneously.

    Device: Foley catheter

Interventions

  • DrugMisoprostol

    Women received intravaginal misoprostol 25 μg 4 hours apart, up to a maximum of four doses.

  • DeviceFoley catheter

    An intracervical Foley catheter (16 F) was inserted into the patients. The balloon was inflated with 30 mL of sterile normal saline solution and was kept in place until it expelled spontaneously.

06

What researchers measure

Primary outcomes

  1. Delivery of the fetus

    Induction-to-delivery interval was calculated from the insertion of the Foley catheter or misoprostol until the delivery of the fetus in hours.

    Time frame: 24 hours

07

Study locations

1 site
  • D.G. Khan Medical College/Allama Iqbal Teaching Hospital
    Dera Ghazi Khan, Punjab Province 32200, Pakistan
08

References and documents

Individual participant data

Plan to share: No — Data can be shared on a reasonable request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 18, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07416487
Lead sponsor
Muhammad Aamir Latif
Responsible party
Muhammad Aamir Latif (Research Consultant, RESnTEC, Institute of Research) — Sponsor-investigator
First posted
Feb 18, 2026
Start date
Feb 1, 2025
Primary completion
Dec 31, 2025
Completion
Dec 31, 2025
Last update
Feb 18, 2026

Study contacts

Zunera Sumbal
principal investigator · D.G. Khan Medical College/Allama Iqbal Teaching Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion